The highly anticipated financial results for the third quarter of Krystal Biotech (NASDAQ: KRYS) are scheduled to be disclosed on Monday 4th November 2024. This important update will be made available before market open, providing investors and market participants with key information regarding the company's financial status.
According to the forecasts of financial experts on Wall Street, the establishment is poised to announce an anticipated per share $0.90 profit for the quarter. Furthermore, the firm is expected to disclose a total revenue of $82.94 million for this specific period.
During the same quarter of the previous year, the company made public its loss of $0.67 per share, which were derived from a quarterly revenue of $8.56 million.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $291.81 million. Additionally, they forecast the earnings per share to hit profit of $2.55 for the fiscal year.
[stock_market_widget type=”chart” template=”line2″ assets=KRYS range=”1y” interval=”1wk” price_field=”close” heading=”{symbol}” line_width=”2″ gradient_direction=”bottom” gradient_size=”1″ line_color=”#1b6dc1″ area_background_color=”#1b6dc1″ area_background_color2=”#ffffff” axes_color=”#000000″ tooltip_text_color=”#262626″ tooltip_background_color=”#ffffff” range_selector=”false” volume_enabled=”false” axes_enabled=”true” tooltip_enabled=”false” events_enabled=”false” smoothing_enabled=”true” zoom_enabled=”false” save_image_enabled=”false” api=”yahoo-finance”]
Additionally, The company will host a conference call with investors and analysts on 4th November 2024 at 08:30 AM eastern time to review the Q3 2024 financial results.
Krystal Biotech (KRYS) closed Friday's regular trading session at $176.39, indicating a 2.24 percent gain. During the day, KRYS shares traded between $170.82 and $176.49, with a day volume of 287.50 thousand shares.
